Amimestrocel

艾米迈托赛

Report date: 2025/05/26 15:33:57

Base Information

Drug NameAmimestrocel
Drug Alias Name人脐带间充质干细胞（铂生卓越）Human cord mesenchymal stem cellHuman cord mesenchymal stem cell (Platinum life excellence biotech)睿铂生PLEB-001 +[6] 
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsGraft vs Host DiseaseAcute Kidney Injury
Global Approved IndicationsGraft vs Host Disease
Approved Indications in ChinaGraft vs Host Disease
Original Approved Country/TerritoryMainland China
Original Approved Date2025/01/02
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPlatinum Life Excellence Biotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesPla General HospitalPlatinum Life Excellence Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseAcute Kidney Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A